Dsuvia, Sufenta, Dzuveo, Zalviso (sufentanil) is a small molecule pharmaceutical. Sufentanil was first approved as Dsuvia on 1984-05-04. It is used to treat pain in the USA. It has been approved in Europe to treat pain and postoperative pain. The pharmaceutical is active against mu-type opioid receptor. Sufentanil citrate's patents are valid until 2031-07-29 (FDA).
|Trade Name||Dzuveo, Zalviso|
|Indication||pain, postoperative pain|
|Drug Class||Narcotic analgesics (fentanyl derivatives)|